The Trump administration is fast-tracking authorization of the drug remdesivir as a treatment for COVID-19.The Food and Drug Administration (FDA) on Friday announced the drug will receive an “emergency use authorization” after it showed promising results during a clinical trial.Early results released this week showed the drug had modest success in reducing the time COVID-19 patients were in the hospital.President Trump addressed the fast-track…
More Stories
Brazil rolls out COVID-19 vaccination plan
First Pfizer COVID-19 vaccine shipments to be delivered to US distribution sites starting Monday
CDC advisory panel recommends Covid-19 vaccine for people 16 and over